List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 5364 studies with search of: "Antimetabolites"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms
Interventions: Drug: methotrexate;   Drug: leucovorin;   Drug: 5-fluorouracil;   Drug: cyclophosphamide;   Procedure: peripheral blood progenitor cell;   Drug: paclitaxel;   Drug: doxorubicin
2 Recruiting Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Docetaxel, Capecitabine
3 Completed Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer
Conditions: Breast Neoplasms;   Neoplasm Metastasis
Intervention: Genetic: peripheral blood progenitor cells carrying MDR1
4 Completed A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients
Condition: Neoplasms
Interventions: Drug: gemcitabine;   Drug: fluorodeoxyuridine;   Drug: leucovorin
5 Recruiting Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
Conditions: Hermanski-Pudlak Syndrome;   Colitis;   Cytokines;   Lymphocytes;   Drug Evaluation
Interventions: Drug: Mesalamine;   Drug: Infliximab;   Drug: Corticosteroids;   Drug: 6-Mercaptopurine;   Drug: Tacrolimus;   Drug: Adalimumab
6 Active, not recruiting Study of Gsmms Interfereon in Metastatic Colorectal Carcinoma
Condition: Colorectal Carcinoma
Interventions: Drug: 5-Fluorouracil;   Drug: Leucovorin Calcium;   Drug: Gamma-Interferon-1b (IFN-γ);   Drug: Bevacizumab
7 Active, not recruiting Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Cancer-Related Problem/Condition;   Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: filgrastim;   Biological: lintuzumab;   Drug: cytarabine;   Drug: etoposide;   Drug: idarubicin
8 Active, not recruiting Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Leukemia;   Lymphoma
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: prednisolone;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Radiation: radiation therapy
9 Active, not recruiting Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: vincristine sulfate
10 Active, not recruiting Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: vinorelbine ditartrate
11 Active, not recruiting Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: aldesleukin;   Biological: allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes;   Drug: fludarabine phosphate;   Procedure: peripheral blood stem cell transplantation
12 Completed Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: fludarabine phosphate
13 Active, not recruiting Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: peripheral blood stem cell transplantation
14 Active, not recruiting Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: graft-versus-tumor induction therapy;   Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
15 Recruiting Two Dose Levels of Capecitabine With Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Anthracycline-Based Chemotherapy
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: docetaxel
16 Active, not recruiting Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: pemetrexed disodium
17 Completed Chemotherapy Consisting of Fludarabine and Cyclophosphamide Followed By White Blood Cell Infusion, Vaccine Therapy, and Aldesleukin in Treating Patients With Recurrent or Refractory Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: fowlpox virus vaccine vector;   Biological: gp100 antigen;   Biological: therapeutic autologous lymphocytes;   Biological: therapeutic tumor infiltrating lymphocytes;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
18 Active, not recruiting PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: midostaurin
19 Completed ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
Conditions: Pancreatic Cancer;   Adenocarcinoma
Intervention: Drug: ARQ 501 in combination with gemcitabine
20 Completed Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Ovarian Cancer;   Vaginal Cancer
Interventions: Drug: capecitabine;   Radiation: brachytherapy;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services